Pipeline for accelerated drug discovery
We use our unique computational methods to discover and design active ingredients for the development of more efficient and affordable medicines.
We discover small molecules which act as inhibitors of disease targets. The endpoint of our process delivers series of compounds which are ready for ADME/tox testing and are patentable. Our focus is on hard-to-drug disease targets, like Protein-Protein Interaction Inhibitors, to treat inflammation and cancer.